• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子样弱凋亡诱导因子(TWEAK)与Fn14。动脉粥样硬化发病机制中的新角色。

TWEAK and Fn14. New players in the pathogenesis of atherosclerosis.

作者信息

Blanco-Colio Luis M, Martín-Ventura Jose L, Munoz-Garcia Begoña, Moreno Juan A, Meilhac Olivier, Ortiz Alberto, Egido Jesus

机构信息

Vascular Research Lab, Fundacion Jimenez Diaz, Autonoma University, Madrid, Spain.

出版信息

Front Biosci. 2007 May 1;12:3648-55. doi: 10.2741/2341.

DOI:10.2741/2341
PMID:17485328
Abstract

Atherosclerosis is currently described as an inflammatory disease given that the main components of chronic inflammation are present in this process: cell recruitment, proliferation, neovascularization, and sclerosis. Vascular lesions are caused by inflammatory and fibroproliferative responses to injury of the endothelium and vascular smooth muscle cells. Interaction between members of the tumor necrosis factor (TNF) superfamily and their receptors elicits diverse biologic actions that participate in atherosclerosis development. These responses include the expression of adhesion molecules, proinflammatory cytokines, matrix metalloproteinases, and tissue factor, which are known to increase plaque instability. TNF-like weak inducer of apoptosis (TWEAK) is a recently described member of the TNF superfamiliy, which is involved in induction of inflammation, activation of cell growth, and stimulation of apoptosis. In this review, we summarize the potential proatherogenic consequences of the interaction of TWEAK with its receptor Fn14 in the vascular wall.

摘要

鉴于慢性炎症的主要成分存在于动脉粥样硬化过程中,包括细胞募集、增殖、新血管形成和硬化,目前动脉粥样硬化被描述为一种炎症性疾病。血管病变是由对内皮细胞和血管平滑肌细胞损伤的炎症和纤维增生反应引起的。肿瘤坏死因子(TNF)超家族成员与其受体之间的相互作用引发了多种参与动脉粥样硬化发展的生物学作用。这些反应包括黏附分子、促炎细胞因子、基质金属蛋白酶和组织因子的表达,已知这些会增加斑块不稳定性。肿瘤坏死因子样凋亡弱诱导剂(TWEAK)是TNF超家族中最近描述的成员,它参与炎症诱导、细胞生长激活和凋亡刺激。在这篇综述中,我们总结了TWEAK与其在血管壁中的受体Fn14相互作用可能产生的促动脉粥样硬化后果。

相似文献

1
TWEAK and Fn14. New players in the pathogenesis of atherosclerosis.肿瘤坏死因子样弱凋亡诱导因子(TWEAK)与Fn14。动脉粥样硬化发病机制中的新角色。
Front Biosci. 2007 May 1;12:3648-55. doi: 10.2741/2341.
2
Role of TWEAK and Fn14 in tumor biology.肿瘤坏死因子样弱凋亡诱导因子(TWEAK)和Fn14在肿瘤生物学中的作用。
Front Biosci. 2007 Jan 1;12:2761-71. doi: 10.2741/2270.
3
Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.TWEAK/Fn14相互作用在肾小球系膜细胞中的促炎作用。
J Immunol. 2006 Feb 1;176(3):1889-98. doi: 10.4049/jimmunol.176.3.1889.
4
TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.肿瘤坏死因子样弱凋亡诱导因子(TWEAK)是肿瘤坏死因子超家族的成员之一,是一种能与肿瘤坏死因子样弱凋亡诱导因子受体(TweakR/Fn14)结合的多功能细胞因子。
Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):241-9. doi: 10.1016/s1359-6101(03)00019-4.
5
TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NFκB.肿瘤坏死因子样弱凋亡诱导因子(TWEAK)通过经典和非经典激活核因子κB(NFκB)促进磷酸盐诱导的血管平滑肌细胞钙化。
Cell Death Dis. 2016 Jul 21;7(7):e2305. doi: 10.1038/cddis.2016.220.
6
Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.肿瘤坏死因子样凋亡弱诱导剂或Fn14缺乏可减少弹性蛋白酶灌注诱导的小鼠腹主动脉瘤。
J Am Heart Assoc. 2014 Aug 4;3(4):e000723. doi: 10.1161/JAHA.113.000723.
7
Tweak and FN14 in central nervous system health and disease.Tweak与FN14在中枢神经系统健康与疾病中的作用
Front Biosci. 2007 May 1;12:2772-81. doi: 10.2741/2271.
8
The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.TWEAK/Fn14在炎症和系统性自身免疫发病机制中的作用。
Front Biosci. 2004 Sep 1;9:2273-84. doi: 10.2741/1395.
9
Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.成纤维细胞生长因子诱导蛋白 14 与肿瘤坏死因子样凋亡弱诱导剂相互作用的结构基础和靶向性。
J Biol Chem. 2013 Nov 8;288(45):32261-32276. doi: 10.1074/jbc.M113.493536. Epub 2013 Sep 20.
10
A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.肿瘤坏死因子样凋亡微弱诱导剂(TWEAK)在心脏功能障碍和衰竭发展中的新作用。
Circulation. 2009 Apr 21;119(15):2058-68. doi: 10.1161/CIRCULATIONAHA.108.837286. Epub 2009 Apr 6.

引用本文的文献

1
Beyond the Finish Line: The Impact and Dynamics of Biomarkers in Physical Exercise-A Narrative Review.超越终点线:生物标志物在体育锻炼中的影响与动态——一篇叙述性综述
J Clin Med. 2021 Oct 27;10(21):4978. doi: 10.3390/jcm10214978.
2
Regular Training Increases sTWEAK and Its Decoy Receptor sCD163-Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect?定期训练可增加可溶性肿瘤坏死因子样弱凋亡诱导因子(sTWEAK)及其诱饵受体可溶性CD163(sCD163)——训练是否会触发sTWEAK/sCD163轴以诱导抗炎作用?
J Clin Med. 2020 Jun 17;9(6):1899. doi: 10.3390/jcm9061899.
3
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges.
肿瘤坏死因子样弱凋亡诱导因子(TWEAK)/成纤维细胞生长因子诱导 14 (Fn14)轴在心血管疾病中的作用:进展与挑战。
Cells. 2020 Feb 11;9(2):405. doi: 10.3390/cells9020405.
4
The role of novel atherosclerosis markers in peripheral artery disease: is there a gender difference?新型动脉粥样硬化标志物在周围动脉疾病中的作用:存在性别差异吗?
Cardiovasc J Afr. 2018;29(5):322-330. doi: 10.5830/CVJA-2018-023. Epub 2018 Apr 20.
5
The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors.肿瘤坏死因子样凋亡微弱诱导剂通过其两种不同受体在动脉粥样硬化中的作用。
Exp Ther Med. 2017 Aug;14(2):891-897. doi: 10.3892/etm.2017.4600. Epub 2017 Jun 14.
6
Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome.系统性红斑狼疮、混合性结缔组织病及抗磷脂综合征病程中的免疫与早期动脉粥样硬化
Reumatologia. 2016;54(4):187-195. doi: 10.5114/reum.2016.62473. Epub 2016 Oct 5.
7
Evaluation of serum sTWEAK and sCD163 levels in patients with acute and chronic coronary artery disease.急性和慢性冠状动脉疾病患者血清可溶性肿瘤坏死因子样弱凋亡诱导因子(sTWEAK)和可溶性血红蛋白清道夫受体(sCD163)水平的评估
Int J Clin Exp Med. 2015 Jun 15;8(6):9394-402. eCollection 2015.
8
T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage.辅助性T细胞17/调节性T细胞平衡与腹膜透析诱导损伤的实验模型
Biomed Res Int. 2015;2015:416480. doi: 10.1155/2015/416480. Epub 2015 May 3.
9
Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.HIV感染患者中可溶性肿瘤坏死因子样弱凋亡诱导因子(sTWEAK)水平降低及可溶性CD163(sCD163)水平升高:抗逆转录病毒治疗、HIV复制及丙型肝炎病毒(HCV)合并感染的调节作用
PLoS One. 2014 Mar 4;9(3):e90541. doi: 10.1371/journal.pone.0090541. eCollection 2014.
10
A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.一组生物标志物与系统性红斑狼疮女性动脉粥样硬化的存在和进展风险增加相关。
Arthritis Rheumatol. 2014 Jan;66(1):130-9. doi: 10.1002/art.38204.